The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Research Funding - EpicentRx
Patents, Royalties, Other Intellectual Property - EpicentRx
Correlation of decreased expression of PD-L1 on circulating tumor cells and clinical benefit in SCLC Patients treated with RRx-001, a CD47 downregulator, in a phase II trial.
 
Corey Carter
No Relationships to Disclose
 
Yusuke Tomita
No Relationships to Disclose
 
Akira Yuno
No Relationships to Disclose
 
Jonathan Baker
No Relationships to Disclose
 
Min-Jung Lee
No Relationships to Disclose
 
Sunmin Lee
No Relationships to Disclose
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Mary Flanagan Quinn
No Relationships to Disclose
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx; EpicentRx (I)
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor of several technologies under EpicentRx. Inc.
 
Tony R. Reid
No Relationships to Disclose
 
Pedro Cabrales
No Relationships to Disclose
 
Nacer Abrouk
No Relationships to Disclose
 
Jane B Trepel
Research Funding - AstraZeneca (Inst); EpicentRX (Inst); Syndax (Inst)